Protalix BioTherapeutics, Inc. Quarterly Depreciation in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
  • Protalix BioTherapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $322K, a 15% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2023 was $1.19M, a 9.67% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2022 was $1.09M, a 2.86% decline from 2021.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2021 was $1.12M, a 14.1% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $322K +$42K +15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $280K +$10K +3.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $270K -$16K -5.59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $286K -$90K -23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $376K -$29K -7.16% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $405K -$25K -5.81% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q1 2018 $430K -$62K -12.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q1 2017 $492K -$24K -4.65% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q1 2016 $516K -$100K -16.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $616K -$212K -25.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $828K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.